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Background
Partial success of the human RV144 clinical trial under-
scored the importance of envelope antibody responses for
an effective HIV-1 vaccine. Immunogenicity studies with
SIV envelope proteins typically neutralize TCLA isolates.
Properly folded trimeric envelope proteins delivered with
appropriate adjuvants may successfully elicit antibodies
with broad neutralization specificity.
Methods
We evaluated immunogenicity of DNA and protein vac-
cines encoding SIVmac251 and SIVsmE660 gp145 in rab-
bits and rhesus macaques. DNA vaccines encoding wild
type gp145 or mutated gp160 truncated at Q708 were
used. Trimeric wildtype gp145 proteins, stably expressed
and purified from 293T cells, were used with Advax delta
inulin adjuvant to boost after DNA immunization. Maca-
ques were electroporated with wild type DNA of both iso-
lates followed by adjuvanted homologous protein boosts.
Rabbits received DNA vaccine alone, delivered by electro-
poration. Neutralization assays were performed in TZM-bl
cells with SIVmac251 and SIVsmE660 isolates that are
partially resistant to neutralization.
Results
Anti-envelope responses to SIV mac251gp145 and
SIVsm660 gp145 were detected in macaque sera following
DNA immunizations and response were enhanced signifi-
cantly after adjuvanted homologous gp145 protein boost.
At peak response, low to moderate neutralizing activity
was observed against SIVmac251/M766, SIVsmE660-BR/
CG7V and SIVmac251.30 clones. Immunization of rabbits
with DNA encoding, either wild type or mutated envelope
elicited strong antibody responses and sera neutralized
both SIVmac251/766 and SIVsmE660-BR/CG7V to a lim-
ited extent, with a comparable response noted for both
wild type and mutant envelope.
Conclusion
Antibody response elicited by DNA prime/Advax adju-
vanted protein boost vaccine with oligomeric envelopes
from both SIVmac251 and SIVsmE660 neutralized SIV-
mac251 and SIVsmE660 isolates of partially resistant phe-
notype. These envelopes together with other antigens that
elicit cellular responses will be tested against SIV challenge
in future efficacy studies.
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